Skip to main navigation Skip to search Skip to main content

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline

  • Richard E. Pratley
  • , Stephan Jacob
  • , Seungjae Baek
  • , Michael E. Trautmann
  • , Marcus Hompesch
  • , Oakpil Han
  • , John Stewart
  • , Christopher H. Sorli
  • , Alka Shaunik
  • , Kun Ho Yoon
  • AdventHealth Central Florida
  • Praxis fur Pravention und Therapie
  • Hanmi Pharmaceutical Co., Ltd.
  • ProSciento
  • Sanofi Canada
  • Sanofi-Aventis

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience